[{"Assets_0_Q1_USD":259452000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":26181000.0,"NetIncomeLoss_1_Q1_USD":8973000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":13925227.0,"StockholdersEquity_0_Q1_USD":175361000.0,"EarningsPerShareBasic_1_Q1_USD":0.64,"Ticker":"EGRX","CIK":"827871","name":"EAGLE PHARMACEUTICALS, INC.","OfficialName":"Eagle Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"635235963.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190507"}]